NCT05046808View on ClinicalTrials.gov

Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

October 8, 2021

Study Completion Date

November 22, 2021

Conditions
Solid Tumor
Interventions
DRUG

Famitinib Malate Capsules

Famitinib Malate Capsules 10mg single dose

DRUG

Famitinib Malate Capsules

Famitinib Malate Capsules 15mg single dose

DRUG

Famitinib Malate Capsules

Famitinib Malate Capsules 20mg single dose

DRUG

Famitinib Malate Capsules

Famitinib Malate Capsules 10mg\*2 single dose

DRUG

Famitinib Malate Capsules

Famitinib Malate Capsules 25mg single dose

Trial Locations (1)

410008

Xiangya Hospital Central South University, Changsha

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05046808 - Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects | Biotech Hunter | Biotech Hunter